Disparities in cancer clinical trials: An analysis of comprehensive cancer control plans

Preventing Chronic Disease

Volumn 6, Issue 4, 2009, Pages

  Felder, Tisha Moniek ^a   Pena, Gabriela D ^b   Chapital, Bridget F ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; EDUCATION; ETHICS; ETHNIC GROUP; HEALTH EDUCATION; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; METHODOLOGY; NEOPLASM; PROGRAM DEVELOPMENT; PUBLIC HEALTH; RACE; REIMBURSEMENT; SOCIOECONOMICS;

CLINICAL TRIALS AS TOPIC; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HEALTH EDUCATION; HEALTH PROMOTION; HEALTH SERVICES; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; NEOPLASMS; PROGRAM DEVELOPMENT; PUBLIC HEALTH; SOCIOECONOMIC FACTORS;

EID: 73349096309     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tournoux C, Katsahian S, Chevret S, Levy V. Factors influencing inclusion of patients with malignancies in clinical trials. Cancer 2006;106(2):258-70.
2. Baseline study of patient accrual onto publicly sponsored US cancer clinical trials: an analysis conducted for the Global Access Project of the National Patient Advocate Foundation. Philadelphia (PA): Coalition of Cancer Cooperative Groups; 2006. http://www.npaf.org/images/pdf/gap/sept_2006/cccg.pdf. Accessed April 21, 2009.
3. Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004;22(22):4626-31.
4. Paskett ED, Cooper MR, Stark N, Ricketts TC, Tropman S, Hatzell T, et al. Clinical trial enrollment of rural patients with cancer. Cancer Pract 2002;10(1):28-35.
5. Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20(8):2109-17.
6. Major deficiencies in the design and funding of clinical trials: a report to the nation improving on how human studies are conducted. Houston (TX): Chronic Disease Prevention and Control Research Center at Baylor College of Medicine, Intercultural Cancer Council; 2008. http://www.bcm.edu/edict/PDF/EDICT_Project_White_Paper.pdf. Accessed April 21, 2009.
7. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research; 1979. http://www.fda.gov/OHRMS/DOCKETS/AC/05/briefing/2005-4178b_09_02_Belmont%20Report.pdf. Accessed April 21, 2009.
8. Pub L No. 103-43.
9. Pub L No. 105-115.
10. Comis RL, Miller JD, Aldigé CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21(5):830-5.
11. Chandra A, Paul DP 3rd. African American participation in clinical trials: recruitment difficulties and potential remedies. Hosp Top 2003;81(2):33-8.
12. Ford JG, Howerton MW, Bolen S, Gary TL, Lai GY, Tilburt J, et al. Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report/Technology Assessment No. 122. Rockville (MD): Agency for Healthcare Research and Quality; 2005. http://www.ahrq.gov/downloads/pub/evidence/pdf/recruitcantrials/recruit.pdf. Accessed April 23, 2009.
13. Simon MS, Du W, Flaherty L, Philip PA, Lorusso P, Miree C, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 2004;22(11):2046-52.
14. National Comprehensive Cancer Control Program (NCCCP) - leadership institutes. Atlanta (GA): Centers for Disease Control and Prevention; 2007. http://www.cdc.gov/cancer/ncccp/institutes/. Accessed April 21, 2009.
15. Comprehensive cancer control plans, additional information, March 2006. Atlanta (GA): Centers for Disease Control and Prevention, 2006.
16. State laws addressing third-party reimbursement for clinical trials for the treatment of cancer (as of September 30, 2007). Bethesda (MD): National Cancer Institute, State Cancer Legislative Database Program; 2007. http://www.scld-nci.net/Data/clinical_trials_reimbursement_09_30_07.pdf. Accessed April 21, 2009.
17. Bernard HR. Research methods in anthropology: qualitative and quantitative approaches. Lanham (MD): Rowman Altamira Press; 2006.
18. Hightower D. Minority participation in clinical trials. Benchmarks 2006;6(4):1.
19. Comis RL, Aldigé CR, Stovall EL, Krebs LU, Risher PJ, Taylor HJ. A quantitative survey of public attitudes towards cancer clinical trials. Philadelphia (PA): Coalition of National Cancer Cooperative Groups, Cancer Research Foundation of America, Cancer Leadership Council and Oncology Nursing Society, 2000. http://www.cancertrialshelp.org/CTHpdf/308-9.pdf. Accessed April 22, 2009.
20. Gross CP, Murthy V, Li Y, Kaluzny AD, Krumholz HM. Cancer trial enrollment after state-mandated reimbursement. J Natl Cancer Inst 2004;96(14):1063-9.
21. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J 2004;10(5):294-300.
22. National Comprehensive Cancer Control Program (NCCCP) - state program highlights. Atlanta (GA): Centers for Disease Control and Prevention; 2008. http://www.cdc.gov/cancer/ncccp/state.htm. Accessed April 21, 2009.
23. Turning commitment into action: Delaware Cancer Consortium year 4 accomplishments, July 2004-June 2007. Delaware Cancer Consortium. http://www.dhss.delaware.gov/dph/dpc/files/finalgreenbook.pdf. Accessed April 21, 2009.
24. Cancer plan Minnesota: progress report 2009. Minnesota Cancer Alliance. http://www2.mncanceralliance.org/sites/528d17b0-2c73-45c9-894d-872fc0beac4e/uploads/CPM_Progress_Report_2009_5.pdf. Accessed April 21, 2009.
25. Thomson GE, Mitchell F, Williams MB. Examining the health disparities research plan of the National Institutes of Health: unfinished business. Washington (DC): National Academies Press; 2006.
26. Steele CB, Thomas CN, Richardson LC. Human papillomavirus-related content in state and tribal comprehensive cancer control plans. J Womens Health (Larchmt) 2008;17(1):5-10.
27. Kilfoy BA, Hudmon KS, Mande JR. Tobacco control in state comprehensive cancer control plans: opportunities for decreasing tobacco-related disease. Prev Chronic Dis 2007;4(3). http://www.cdc.gov/pcd/issues/2007/jul/06_0092.htm.